QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mizoguchi, H. Articles by Nabeshima, T. Search for Related Content PubMed PubMed Citation Articles by Mizoguchi, H. Articles by Nabeshima, T.

Regulations of Methamphetamine Reward by Extracellular Signal-Regulated Kinase 1/2/ets-Like Gene-1 Signaling Pathway via the Activation of Dopamine Receptors

Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan (H.M., K.Y., M.M., T.M., A.N., Y.N., T.N.); and Laboratory of Neuropsychopharmacology, Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Kanazawa University, Kanazawa, Japan (K.Y.)

Little is known about molecular mechanisms for long-lasting neuroadaptation related to the rewarding effects of methamphetamine (MAP). In the present study, we examined the intracellular signaling that is associated with the expression of conditioned place preference (CPP) induced by MAP in rats. Rats were given MAP or saline (control group) for conditioning to the CPP test. MAP-treated and control animals were killed immediately after the CPP test [CPP⁺]. Some of the MAP-treated rats were killed without the CPP test [CPP^-]. Hyperphosphorylation of mitogen-activated protein kinase (MAPK) ERK1/2, but not p38 and c-Jun N-terminal kinase/stress-activated protein kinase, was found in the nucleus accumbens (NAc) and striatum but not in other brain areas of MAP-treated CPP⁺ animals. No such phosphorylation was seen in control and MAP-treated CPP^- animals. Moreover, the transcription factor ets-like gene-1 (Elk-1), but not cAMP response element-binding protein, also showed a similar hyperphosphorylation in the same regions of MAP-treated CPP⁺. Tyrosine kinase receptors, including tyrosine kinase B, were not activated in any brain regions examined in all groups. Both the dopamine D1 receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH23390 and the D2 receptor antagonist raclopride inhibited the expression of CPP as well as the activation of ERK1/2 in MAP-treated CPP⁺ animals, when they were injected before the CPP test. The microinjection of 2'-amino-3'-methoxyflavone (PD98059), a selective MAPK kinase inhibitor, into the NAc before the test, abolished the MAP-induced ERK1/2 activation and decreased the expression of MAP-induced CPP. These results suggest the importance of the ERK1/2 signaling pathway through activation of dopamine D1 and D2 receptors in the expression of CPP induced by MAP.

Address correspondence to: Dr. Toshitaka Nabeshima, Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8560, Japan. E-mail: tnabeshi{at}med.nagoya-u.ac.jp

This article has been cited by other articles:

				J. Bertran-Gonzalez, C. Bosch, M. Maroteaux, M. Matamales, D. Herve, E. Valjent, and J.-A. Girault Opposing Patterns of Signaling Activation in Dopamine D1 and D2 Receptor-Expressing Striatal Neurons in Response to Cocaine and Haloperidol J. Neurosci., May 28, 2008; 28(22): 5671 - 5685. [Abstract] [Full Text] [PDF]

				M. Niwa, A. Nitta, H. Mizoguchi, Y. Ito, Y. Noda, T. Nagai, and T. Nabeshima A Novel Molecule "Shati" Is Involved in Methamphetamine-Induced Hyperlocomotion, Sensitization, and Conditioned Place Preference J. Neurosci., July 11, 2007; 27(28): 7604 - 7615. [Abstract] [Full Text] [PDF]

				Y. Yan, K. Yamada, M. Niwa, T. Nagai, A. Nitta, and T. Nabeshima Enduring vulnerability to reinstatement of methamphetamine-seeking behavior in glial cell line-derived neurotrophic factor mutant mice FASEB J, July 1, 2007; 21(9): 1994 - 2004. [Abstract] [Full Text] [PDF]

				T. Nagai, K. Takuma, H. Kamei, Y. Ito, N. Nakamichi, D. Ibi, Y. Nakanishi, M. Murai, H. Mizoguchi, T. Nabeshima, et al. Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex Learn. Mem., March 2, 2007; 14(3): 117 - 125. [Abstract] [Full Text] [PDF]

				Y. Ito, K. Takuma, H. Mizoguchi, T. Nagai, and K. Yamada A Novel Azaindolizinone Derivative ZSET1446 (Spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one) Improves Methamphetamine-Induced Impairment of Recognition Memory in Mice by Activating Extracellular Signal-Regulated Kinase 1/2 J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 819 - 827. [Abstract] [Full Text] [PDF]

				J. McDaid, M. P. Graham, and T. C. Napier Methamphetamine-Induced Sensitization Differentially Alters pCREB and {Delta}FosB throughout the Limbic Circuit of the Mammalian Brain Mol. Pharmacol., December 1, 2006; 70(6): 2064 - 2074. [Abstract] [Full Text] [PDF]

				C. A. Miller and J. D. Sweatt Amnesia or retrieval deficit? Implications of a molecular approach to the question of reconsolidation. Learn. Mem., September 1, 2006; 13(5): 498 - 505. [Abstract] [Full Text] [PDF]

				E. Valjent, A.-G. Corbille, J. Bertran-Gonzalez, D. Herve, and J.-A. Girault Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference PNAS, February 21, 2006; 103(8): 2932 - 2937. [Abstract] [Full Text] [PDF]